V-Bio Ventures and Advent France Biotechnology have co-led a €21m funding round for Belgium-based AgomAb Therapeutics, with participation from Boehringer Ingelheim Venture Fund, Omnes and Pontifax.
GP intends to accelerate the company's organic growth and boost its international expansion
Founder sells a majority stake in the trucks and vehicles business to the management team and GPs
Enact II makes its third investment with the carbon-based products manufacturer
Sale ends a three-year holding period for Hat, which owned a 96.35% stake in the business